Literature DB >> 9278251

Glycosylation of asparagine 24 of the natriuretic peptide receptor-B is crucial for the formation of a competent ligand binding domain.

R Fenrick1, N Bouchard, N McNicoll, A De Léan.   

Abstract

UV cross-linking studies of the natriuretic peptide receptor-B (NPR-B) using radiolabeled C-type natriuretic peptide (CNP) indicate that only fully glycosylated receptors are capable of binding ligand. We therefore used site-directed mutagenesis to determine which potential glycosylation sites are occupied by carbohydrate, and the relevant mutants were characterized in order to understand the function of carbohydrate addition at those sites. Our results suggest that five of seven potential N-linked glycosylation sites are modified. In addition, mutation of asparagine 24 results in a loss of approximately 90% of receptor activity. This mutant is expressed at levels comparable to the wild-type receptor, and its activity is not significantly different from that of wild-type NPR-B in terms of EC50 for CNP. Ligand binding studies on this mutant further show that although there is no change in affinity for ligand, approximately 90% of receptor binding is lost. These data suggest that many of the mutant receptors are simply not properly folded. Our results indicate that glycosylation of asparagine 24 of NPR-B receptors may be critical for the formation of a competent ligand binding domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278251     DOI: 10.1023/a:1006855522272

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

Review 1.  Diverse biological actions of atrial natriuretic peptide.

Authors:  B M Brenner; B J Ballermann; M E Gunning; M L Zeidel
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

2.  Distinct properties of atrial natriuretic factor receptor subpopulations in epithelial and fibroblast cell lines.

Authors:  J Féthière; S Meloche; T T Nguyen; H Ong; A De Lean
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

3.  Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera.

Authors:  B D Bennett; G L Bennett; R V Vitangcol; J R Jewett; J Burnier; W Henzel; D G Lowe
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

4.  The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family.

Authors:  S Schulz; S Singh; R A Bellet; G Singh; D J Tubb; H Chin; D L Garbers
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

5.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  Photoaffinity labelling of atrial natriuretic factor (ANF)-R1 receptor by underivatized 125I-ANF. Involvement of lipid peroxidation.

Authors:  L Larose; N McNicoll; J J Rondeau; E Escher; A De Lean
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

8.  The disulfide linkages and glycosylation sites of the human natriuretic peptide receptor-C homodimer.

Authors:  J T Stults; K L O'Connell; C Garcia; S Wong; A M Engel; D L Garbers; D G Lowe
Journal:  Biochemistry       Date:  1994-09-20       Impact factor: 3.162

9.  Agonist selectivity for three species of natriuretic peptide receptor-A.

Authors:  J R Schoenfeld; P Sehl; C Quan; J P Burnier; D G Lowe
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

10.  Cardiovascular and renal actions of C-type natriuretic peptide.

Authors:  A J Stingo; A L Clavell; L L Aarhus; J C Burnett
Journal:  Am J Physiol       Date:  1992-01
View more
  9 in total

Review 1.  Natriuretic peptide receptor: structure and signaling.

Authors:  Kunio S Misono
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 3.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

4.  Comparative binding study of rat natriuretic peptide receptor-A.

Authors:  M Marquis; R Fenrick; L Pedro; M Bouvier; A De Léan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

5.  Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism.

Authors:  Deborah M Dickey; Aaron B Edmund; Neil M Otto; Thomas S Chaffee; Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2016-03-15       Impact factor: 5.157

6.  Glycosylation of the receptor guanylate cyclase C: role in ligand binding and catalytic activity.

Authors:  Yashoda Ghanekar; Akhila Chandrashaker; Utpal Tatu; Sandhya S Visweswariah
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

7.  Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36.

Authors:  Najla Arshad; Suhas Ballal; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2012-12-26       Impact factor: 5.157

8.  Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation.

Authors:  Kailash N Pandey
Journal:  J Am Soc Hypertens       Date:  2008 Jul-Aug

Review 9.  Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.

Authors:  Kailash N Pandey
Journal:  Front Mol Neurosci       Date:  2014-08-22       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.